A conference focused on improving drug development processes.
C-Path Global Impact Conference
['FUNDING_OTHER'] · CRITICAL PATH INSTITUTE · NIH-11075617
The C-Path Global Impact Conference is a friendly gathering where people from different areas, like medicine and patient advocacy, come together to share new ideas and solutions to make developing safe and effective medicines faster and better, especially for tough health issues like neurological disorders, rare diseases, and kids' health.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | CRITICAL PATH INSTITUTE (nih funded) |
| Locations | 1 site (TUCSON, UNITED STATES) |
| Trial ID | NIH-11075617 on ClinicalTrials.gov |
What this research studies
The C-Path Global Impact Conference is a four-day event aimed at showcasing innovative solutions to enhance the efficiency and safety of medical product development. It brings together various stakeholders, including regulatory agencies, pharmaceutical companies, and patient groups, to foster collaboration and dialogue. Attendees will discuss advancements in developing novel therapeutics for challenging conditions, particularly in neurology, rare diseases, and pediatric populations. This conference serves as a platform for sharing knowledge and strategies to optimize drug evaluation processes.
Who could benefit from this research
Good fit: Patients with conditions in neurology, rare diseases, or pediatric populations may benefit from the advancements discussed at this conference.
Not a fit: Patients with conditions not addressed by the conference's focus on drug development may not receive direct benefits.
Why it matters
Potential benefit: If successful, this conference could lead to improved drug development processes, resulting in safer and more effective treatments for patients.
How similar studies have performed: Previous conferences and collaborations in drug development have shown success in fostering innovation and improving treatment pathways.
Where this research is happening
TUCSON, UNITED STATES
- CRITICAL PATH INSTITUTE — TUCSON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ROMERO, KLAUS — CRITICAL PATH INSTITUTE
- Study coordinator: ROMERO, KLAUS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.